Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 112665-43-7 Chemical Structure| 112665-43-7

Structure of Seratrodast
CAS No.: 112665-43-7

Chemical Structure| 112665-43-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Seratrodast is a potent and selective thromboxane A2 receptor (TP) antagonist.

Synonyms: AA 2414; A-73001; CCRIS 8939.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Seratrodast

CAS No. :112665-43-7
Formula : C22H26O4
M.W : 354.44
SMILES Code : O=C(O)CCCCCC(C1=C(C)C(C(C)=C(C)C1=O)=O)C2=CC=CC=C2
Synonyms :
AA 2414; A-73001; CCRIS 8939.
InChI Key :ZBVKEHDGYSLCCC-UHFFFAOYSA-N
Pubchem ID :2449

Safety of Seratrodast

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H360
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02716246 Mucopolysaccharidosis Type 3 A... More >> Sanfilippo Syndrome Less << Phase 1 Phase 2 Recruiting December 2020 United States, Ohio ... More >> Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Krista Kunkler    614-722-2238    krista.kunkler@nationwidechildrens.org    Australia, South Australia Women's and Children's Hospital Recruiting North Adelaide, South Australia, Australia, 5006 Contact: Louise Jaensch    08 8161 7295    louise.jaensch@sa.gov.au    Principal Investigator: Nicholas Smith, MD          Spain Hospital Clínico Universitario de Santiago Recruiting Santiago De Compostela, Spain, 15706 Contact: Maria Luz Couce, MD    +34 981 950 151    maria.luz.couce.pico@sergas.es    Contact: Maria Jose de Castro, MD    +34 981 955 627    maria.jose.de.castro.lopez@sergas.es Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.82mL

0.56mL

0.28mL

14.11mL

2.82mL

1.41mL

28.21mL

5.64mL

2.82mL

References

 

Historical Records

Categories